Subsidies Provided for In-Vitro Fertilisation (IVF) Treatments in Past Five Years and Expected Increase in Subsidies Expenditure
Ministry of HealthSpeakers
Summary
This question concerns the total subsidies provided for In-Vitro Fertilisation (IVF) and the projected costs of extending co-funding beyond current limits, as raised by Mr Louis Ng Kok Kwang. Minister for Health Mr Gan Kim Yong stated that annual co-funding grew from $14 million in 2015 to $20 million in 2019, covering up to 75% of costs for six cycles. He noted that support is based on clinical evidence showing success rates drop from 24.6% for women under 35 to just 6.7% for those aged 40 and above. In 2019, 48 couples utilised their sixth cycle, though the Minister highlighted that success decreases while emotional strain increases with successive attempts. Minister for Health Mr Gan Kim Yong concluded that the current limit balances parenthood support with evidence-based, targeted use of public funds.
Transcript
18 Mr Louis Ng Kok Kwang asked the Minister for Health (a) for each year in the past five years, what is the total amount of subsidies provided for In-Vitro Fertilisation (IVF) treatments; and (b) based on current amount of subsidies and data, what is the expected increase in subsidies expenditure where subsidies are provided beyond the current three fresh and three frozen subsidised cycles for (i) an additional fresh cycle (ii) an additional frozen cycle (iii) two additional fresh cycles and (iv) two additional frozen cycles respectively.
Mr Gan Kim Yong: To support couples in fulfilling their marriage and parenthood aspirations, the Government provides co-funding for patients seeking Assisted Reproduction Technology (ART) procedures, including In-Vitro Fertilisation (IVF), to defray their out-of-pocket costs for such procedures at public hospitals. Eligible couples1 can receive up to 75% in co-funding from the Government for ART treatment cycles, for a maximum of three fresh and three frozen ART cycles. From 2015 to 2019, annual co-funding provided has increased2 more than 40% from approximately $14 million in 2015 to $20 million in 2019.
Government support for ART is based on clinical evidence that the success rate of ART decreases for successive cycles as a woman progresses in age. In 2019, among the 48 couples who utilised their sixth co-funded cycle, close to 75% of the women were aged 35 and above at the time of their sixth co-funded cycle. Clinical data shows that while success rates exceed 24.6% for women aged 34 and below, this falls to 17.1% for women from ages 35 to 39, and falls further to 6.7% for those aged 40 and above. Given the significantly lower success rate for couples undergoing additional co-funded cycles beyond the sixth cycle, it is important that we remain grounded by the clinical evidence when extending co-funding to more cycles at this point, while bearing in mind that the couple will still be subject to the emotional strain faced in each attempt. Hence, we must continue to encourage couples to seek treatment early, in order to maximise the chances of conception.
Co-funding of six cycles hence strikes a balance between providing financial support to couples with parenthood aspirations and ensuring that public funds are used in a targeted way.